📰 Abt News
Page 186 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 3, 2023
Halbert Hargrove Global Advisors LLC increased its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 4.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,788 shares of the healthcare product maker’s stock after purchasing an additional 117 shares during the […]
April 3, 2023
Beaumont Financial Advisors LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 74,594 shares of the healthcare product maker’s stock, valued at approximately $8,190,000. Abbott Laboratories comprises about 0.8% of Beaumont Financial […]
April 3, 2023
Bard Financial Services Inc. decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.8% during the 4th quarter, Holdings Channel reports. The firm owned 64,150 shares of the healthcare product maker’s stock after selling 1,150 shares during the quarter. Bard Financial Services Inc.’s holdings in Abbott Laboratories were worth $7,043,000 at […]
April 3, 2023
Fifth Third Bancorp decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,176,094 shares of the healthcare product maker’s stock after selling 5,637 shares during the quarter. Fifth Third Bancorp’s holdings in Abbott Laboratories were worth $129,123,000 at the end […]
April 3, 2023
Brown Financial Advisory bought a new position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,904 shares of the healthcare product maker’s stock, valued at approximately $209,000. Abbott Laboratories comprises about 0.2% of Brown […]
April 2, 2023
Arcblock (ABT) traded down 0.8% against the U.S. dollar during the 1 day period ending at 19:00 PM E.T. on April 1st. One Arcblock token can currently be purchased for about $0.13 or 0.00000460 BTC on cryptocurrency exchanges. Arcblock has a market capitalization of $12.93 million and $161,752.03 worth of Arcblock was traded on exchanges […]
April 2, 2023
Phillips Financial Management LLC bought a new stake in Abbott Laboratories (NYSE:ABT – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 2,013 shares of the healthcare product maker’s stock, valued at approximately $221,000. A number of other […]
April 2, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its price objective boosted by stock analysts at SVB Leerink from $90.00 to $102.00 in a report issued on Friday, Stock Target Advisor reports. The brokerage presently has a “market perform” rating on the healthcare product maker’s stock. SVB Leerink’s price target indicates a potential upside of 0.73% […]
April 2, 2023
Park Avenue Securities LLC lessened its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 0.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 53,960 shares of the healthcare product maker’s stock after selling 273 shares during the quarter. Park Avenue Securities LLC’s holdings […]
April 2, 2023
Asset Management Corp IL ADV reduced its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 5.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,583 shares of the healthcare product maker’s stock after selling 537 shares during the period. Abbott […]